Impulse Dynamics said Wednesday that it has raised $158 million to commercialize and further develop its heart failure treatment. The Food and Drug Administration approved Impulse's Optimizer system ...

The sinoatrial (SA) node is the natural pacemaker of the heart. It generates electrical impulses that cause the heart’s chambers to contract, setting the heart rate. The SA node typically generates 60 ...

Impulse Dynamics raised $45 million in equity for its device that treats chronic heart failure by delivering electrical pulses to boost the heart’s ability to contract. The company’s technology, ...

The FDA has approved another one of its breakthrough devices: an implant from Impulse Dynamics designed for patients with chronic heart failure who aren’t able to use a pacemaker or standard cardiac ...

The rhythm in a working heart is regulated by electrical impulses. Disturbances of this bioelectrical process can result in cardiac arrhythmias, or irregularities in heartbeat -- a common ailment that ...